Chenguang Zhao1,
Patrick Bolan2, Melanie Royce3, Lavneeth Lakkadi2,
Sang-Joon Lee4, Steve Eberhard5, Stefan Posse1,6
1Neurology,
University of New Mexico, Albuquerque, NM, USA; 2CMRR, University
of Minnesota, Minneapolis, MN, USA; 3Medical Oncology, University
of New Mexico, Albuquerque, NM, USA; 4Internal Medicine,
University of New Mexico, Albuquerque, NM, USA; 5Radiology,
University of New Mexico, Albuquerque, NM, USA; 6Electrical &
Computer Engineering, University of New Mexico, Albuquerque, NM, USA
This study investigates the feasibility of using high-speed Proton-Echo-Planar-Spectroscopic-Imaging (PEPSI) to map a key biomarker, total Choline (tCho) in breast cancer. In a patient with locally advanced infiltrating ductal carcinoma, the tCho concentration measured in 9 voxels was 14.65.4 mmol/kg using PEPSI vs. 12.78.0 mmol/kg using PRESS CSI. In a group of healthy controls, the slice averaged tCho concentration measured using PEPSI was 0.480.2 mmol/kg. This was consistent with measurement using PRESS CSI (0.56 0.44mmol/kg) and PRESS single voxel Spectroscopy (0.69 0.6 mmol/kg).